Rhumbline Advisers Agilent Technologies, Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 581,199 shares of A stock, worth $80.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

581,199

Previous 627,671 7.4%

Holding current value

$80.1 Million

Previous $91.3 Million 17.51%

% of portfolio

0.07%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$129.63 - $154.64 $6.02 Million - $7.19 Million	-46,472 Reduced 7.4%	581,199 $75.3 Million
Q1 2024 May 09, 2024	BUY	$128.12 - $149.31 $187,055 - $217,992	1,460 Added 0.23%	627,671 $91.3 Million
Q4 2023 Feb 08, 2024	SELL	$101.17 - $139.82 $213,165 - $294,600	-2,107 Reduced 0.34%	626,211 $87.1 Million
Q3 2023 Nov 09, 2023	BUY	$109.73 - $128.47 $877,840 - $1.03 Million	8,000 Added 1.29%	628,318 $70.3 Million
Q2 2023 Aug 08, 2023	BUY	$114.69 - $141.28 $196,349 - $241,871	1,712 Added 0.28%	620,318 $74.6 Million
Q1 2023 May 11, 2023	BUY	$131.13 - $159.06 $3.08 Million - $3.74 Million	23,521 Added 3.95%	618,606 $85.6 Million
Q4 2022 Feb 14, 2023	BUY	$125.64 - $157.68 $2.29 Million - $2.87 Million	18,192 Added 3.15%	595,085 $89.1 Million
Q3 2022 Nov 10, 2022	BUY	$115.11 - $142.29 $5.03 Million - $6.21 Million	43,660 Added 8.19%	576,893 $70.1 Million
Q2 2022 Aug 11, 2022	BUY	$112.71 - $135.93 $5.38 Million - $6.49 Million	47,768 Added 9.84%	533,233 $63.3 Million
Q1 2022 May 12, 2022	SELL	$126.0 - $156.48 $1.52 Million - $1.89 Million	-12,083 Reduced 2.43%	485,465 $64.2 Million
Q4 2021 Feb 10, 2022	BUY	$147.95 - $164.3 $1.88 Million - $2.09 Million	12,725 Added 2.62%	497,548 $79.4 Million
Q3 2021 Nov 12, 2021	BUY	$147.58 - $179.28 $432,114 - $524,931	2,928 Added 0.61%	484,823 $76.4 Million
Q2 2021 Aug 05, 2021	SELL	$127.69 - $148.81 $125,774 - $146,577	-985 Reduced 0.2%	481,895 $71.2 Million
Q1 2021 May 06, 2021	SELL	$114.99 - $130.12 $4.16 Million - $4.7 Million	-36,138 Reduced 6.96%	482,880 $61.4 Million
Q4 2020 Feb 10, 2021	SELL	$100.01 - $119.3 $344,734 - $411,227	-3,447 Reduced 0.66%	519,018 $61.5 Million
Q3 2020 Nov 12, 2020	BUY	$88.11 - $103.42 $2.21 Million - $2.59 Million	25,047 Added 5.04%	522,465 $52.7 Million
Q2 2020 Aug 13, 2020	SELL	$68.92 - $91.14 $592,918 - $784,077	-8,603 Reduced 1.7%	497,418 $44 Million
Q1 2020 May 06, 2020	BUY	$63.37 - $90.13 $1.88 Million - $2.67 Million	29,664 Added 6.23%	506,021 $36.2 Million
Q4 2019 Feb 05, 2020	BUY	$72.49 - $85.45 $74,664 - $88,013	1,030 Added 0.22%	476,357 $40.6 Million
Q3 2019 Oct 23, 2019	SELL	$65.59 - $78.07 $28,269 - $33,648	-431 Reduced 0.09%	475,327 $36.4 Million
Q2 2019 Aug 14, 2019	BUY	$66.89 - $81.94 $951,710 - $1.17 Million	14,228 Added 3.08%	475,758 $35.5 Million
Q1 2019 May 01, 2019	SELL	$63.27 - $82.0 $4.19 Million - $5.43 Million	-66,177 Reduced 12.54%	461,530 $37.1 Million
Q4 2018 Jan 31, 2019	SELL	$61.13 - $74.67 $953,077 - $1.16 Million	-15,591 Reduced 2.87%	527,707 $35.6 Million
Q3 2018 Nov 07, 2018	SELL	$61.25 - $71.13 $627,873 - $729,153	-10,251 Reduced 1.85%	543,298 $38.3 Million
Q2 2018 Aug 06, 2018	SELL	$61.14 - $69.55 $72,206 - $82,138	-1,181 Reduced 0.21%	553,549 $34.2 Million
Q1 2018 May 02, 2018	SELL	$65.05 - $74.82 $259,809 - $298,831	-3,994 Reduced 0.71%	554,730 $37.1 Million
Q4 2017 Feb 09, 2018	BUY	$64.87 - $70.59 $612,243 - $666,228	9,438 Added 1.72%	558,724 $37.4 Million
Q3 2017 Nov 06, 2017	BUY	$58.57 - $66.17 $32.2 Million - $36.3 Million	549,286	549,286 $35.3 Million

Others Institutions Holding A

# of Institutions

1,130

Shares Held

258M

Call Options Held

1.11M

Put Options Held

970K

View Full List

About AGILENT TECHNOLOGIES, INC.

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $40.8B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

More about A

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Agilent Technologies, Inc. Transaction History